Status:

COMPLETED

NIRS Ticagrelor Evaluation

Lead Sponsor:

Medstar Health Research Institute

Collaborating Sponsors:

AstraZeneca

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The Impact of Ticagrelor on Coronary Atherosclerotic Lipid Pool and Inflammation Assessed by Near-Infrared Spectroscopy study will evaluate whether ticagrelor leads to a 20% reduction in the LCBI with...

Detailed Description

Single-Center, open-label study of the effect of ticagrelor on the reduction in the lipid pool in 30 patients with multi-vessel CAD 2 Treatment periods over 6 months, with 2 additional follow-up phone...

Eligibility Criteria

Inclusion

  • • Female (post menopausal or surgically sterile) and/or male aged 18 years or older
  • Multi-vessel coronary artery disease CAD
  • Statin therapy for minimum of 6 weeks prior to enrollment in the study with no plan for further adjustment
  • Non-emergent PCI for ACS with stent placement requiring dual-antiplatelet therapy
  • Ability to safely perform NIRS/IVUS for a concomitant non-culprit lesion with diameter stenosis ≥50% that was not treated with PCI
  • Willing and able to sign informed consent and participate in follow-up

Exclusion

  • Thienopyridine or ticagrelor use in the last month
  • Need for coronary artery bypass surgery or other surgeries during the follow-up period
  • Documented medication non-compliance
  • Chronic inflammatory disorder or treatment with anti-inflammatory or immunosuppressive drugs
  • Prior or current malignancy within the last 5 years
  • Concomitant severe illness or reduced life expectancy that will prevent follow-up cardiac catheterization
  • Active infection
  • Pregnant or lactating women
  • End-stage renal disease
  • History of intracranial hemorrhage
  • Active pathological bleeding
  • Known severe hepatic impairment
  • Known hypersensitivity to ticagrelor

Key Trial Info

Start Date :

June 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2016

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT02282332

Start Date

June 1 2014

End Date

April 1 2016

Last Update

April 8 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.